| Sorafenib resistance in hepatocarcinoma: role of hypoxia-inducible factors C Méndez-Blanco, F Fondevila, A García-Palomo, J González-Gallego, ... Experimental & molecular medicine 50 (10), 1-9, 2018 | 264 | 2018 |
| Melatonin enhances sorafenib actions in human hepatocarcinoma cells by inhibiting mTORC1/p70S6K/HIF-1α and hypoxia-mediated mitophagy N Prieto-Domínguez, C Méndez-Blanco, S Carbajo-Pescador, ... Oncotarget 8 (53), 91402, 2017 | 81 | 2017 |
| Anti-tumoral activity of single and combined regorafenib treatments in preclinical models of liver and gastrointestinal cancers F Fondevila, C Méndez-Blanco, P Fernández-Palanca, ... Experimental & molecular medicine 51 (9), 1-15, 2019 | 74 | 2019 |
| Antitumor effects of quercetin in hepatocarcinoma in vitro and in vivo models: a systematic review P Fernández-Palanca, F Fondevila, C Méndez-Blanco, MJ Tuñón, ... Nutrients 11 (12), 2875, 2019 | 60 | 2019 |
| Melatonin as an antitumor agent against liver cancer: an updated systematic review P Fernández-Palanca, C Méndez-Blanco, F Fondevila, MJ Tuñón, ... Antioxidants 10 (1), 103, 2021 | 34 | 2021 |
| Stabilization of hypoxia-inducible factors and BNIP3 promoter methylation contribute to acquired sorafenib resistance in human hepatocarcinoma cells C Méndez-Blanco, F Fondevila, P Fernández-Palanca, A García-Palomo, ... Cancers 11 (12), 1984, 2019 | 32 | 2019 |
| Prognostic and clinicopathological significance of hypoxia-inducible factors 1α and 2α in hepatocellular carcinoma: A systematic review with meta-analysis C Méndez-Blanco, P Fernández-Palanca, F Fondevila, ... Therapeutic Advances in Medical Oncology 13, 1758835920987071, 2021 | 22 | 2021 |
| Association of FOXO3 expression with tumor pathogenesis, prognosis and clinicopathological features in hepatocellular carcinoma: a systematic review with meta-analysis F Fondevila, P Fernandez-Palanca, C Mendez-Blanco, T Payo-Serafin, ... Cancers 13 (21), 5349, 2021 | 13 | 2021 |
| Neuropilin-1 as a potential biomarker of prognosis and invasive-related parameters in liver and colorectal cancer: A systematic review and meta-analysis of human studies P Fernández-Palanca, T Payo-Serafín, F Fondevila, C Méndez-Blanco, ... Cancers 14 (14), 3455, 2022 | 8 | 2022 |
| Autophagy-related chemoprotection against sorafenib in human hepatocarcinoma: Role of FOXO3 upregulation and modulation by regorafenib F Fondevila, C Mendez-Blanco, P Fernandez-Palanca, T Payo-Serafin, ... International Journal of Molecular Sciences 22 (21), 11770, 2021 | 8 | 2021 |
| Mendez-Blanco et al. Stabilization of Hypoxia-Inducible Factors and BNIP3 Promoter Methylation Contribute to Acquired Sorafenib Resistance in Human Hepatocarcinoma Cells (vol … C Mendez-Blanco, F Fondevila, P Fernandez-Palanca, A Garcia-Palomo, ... Cancers 15 (23), 2023 | | 2023 |
| Correction: Méndez-Blanco et al. Stabilization of Hypoxia-Inducible Factors and BNIP3 Promoter Methylation Contribute to Acquired Sorafenib Resistance in Human Hepatocarcinoma … C Méndez-Blanco, F Fondevila, P Fernández-Palanca, A García-Palomo, ... Cancers 15 (23), 5668, 2023 | | 2023 |
| Role of autophagy-mediated neuropilin-1 degradation on lenvatinib efficacy in human hepatocarcinoma P Fernández-Palanca, T Payo-Serafín, F Fondevila, C Méndez-Blanco, ... Journal of Hepatology 77, S639-S640, 2022 | | 2022 |
| Neuropilin-1 as a Potential Biomarker of Prognosis and Invasive-Related Parameters in Liver and Colorectal Cancer: A Systematic Review and Meta-Analysis of Human Studies … P Fernández-Palanca, T Payo-Serafín, F Fondevila, C Méndez-Blanco, ... s Note: MDPI stays neu-tral with regard to jurisdictional claims in …, 2022 | | 2022 |
| HIF-1 alpha ON PROGNOSIS, RECURRENCE AND ACQUISITION OF RESISTANCE TO SORAFENIB IN HEPATOCARCINOMA C Mendez-Blanco, F Fondevila, P Fernandez-Palanca, F Jorquera, ... HEPATOLOGY 74, 300A-300A, 2021 | | 2021 |
| HIF-2 alpha AS A NOVEL PROGNOSTIC BIOMARKER AND THERAPEUTIC TARGET ASSOCIATED TO SORAFENIB RESISTANCE IN HEPATOCARCINOMA P Fernandez-Palanca, C Mendez-Blanco, F Fondevila, F Jorquera, ... HEPATOLOGY 74, 301A-301A, 2021 | | 2021 |
| FOXO3 AS A NEW BIOMARKER FOR HUMAN HEPATOCARCINOMA: ROLE ON DIAGNOSIS, PROGNOSIS AND AUTOPHAGY-MEDIATED SORAFENIB RESISTANCE ACQUISITION F Fondevila, P Fernandez-Palanca, C Mendez-Blanco, T Payo-Serafin, ... HEPATOLOGY 74, 300A-300A, 2021 | | 2021 |
| Role of hypoxia-inducible factors 1alpha and 2alpha in prognosis and sorafenib chemoresistance in hepatocarcinoma C Mendez-Blanco, F Fondevila, P Fernandez-Palanca, J van Pelt, ... Journal Of Hepatology 75, S504-S505, 2021 | | 2021 |
| Resistance to sorafenib in hepatocarcinoma: role of BCL2 interacting protein 3 promoter hypermethylation P Fernandez-Palanca, C Mendez-Blanco, F Fondevila, J van Pelt, ... Journal Of Hepatology 75, S505-S505, 2021 | | 2021 |
| FOXO3, Autophagy and Sorafenib Resistance in Human Hepatocarcinoma F Fondevila, CM Blanco, P Fernández-Palanca, T Payo-Serafín, ... | | |
CAROLINA MÉNDEZ BLANCOPredoctoral researcher at the Institute of Biomedicine (IBIOMED)-University of LeónDirección de correo verificada de unileon.es
